2型糖尿病患者合并肌少症与骨质疏松关系的研究进展
Research Progress on the Relationship between Sarcopenia and Osteoporosis in Type 2 Diabetes Mellitus
DOI: 10.12677/ACM.2021.117463, PDF,   
作者: 李金霞：青海大学研究生院，青海 西宁；杨历新：青海省人民医院内分泌科，青海 西宁
关键词: 糖尿病；肌少症；骨质疏松；关联性；Diabetes Mellitus； Sarcopenia； Osteoporosis； Correlation
摘要: 一直以来人们所熟知的糖尿病并发症是糖尿病视网膜病变、糖尿病肾病和神经病变等微血管并发症以及心血管疾病等大血管并发症。而随着世界人口老龄化趋势的加重，骨质疏松、肌少症作为老年人高发疾病，目前已有研究证实它们为糖尿病新型并发症。本文就糖尿病、肌少症与骨质疏松之间的相互关系、潜在的生物学机制加以综述，旨在提高人们对糖尿病、肌少症、骨质疏松三者的认识，并为它们的诊断、预防及综合治疗提供新思路。
Abstract: The well-known complications of diabetes mellitus are microvascular complications such as diabetic retinopathy, diabetic nephropathy and neuropathy, and macrovascular complications such as cardiovascular disease. With the aggravation of the aging trend of the world population, osteoporosis and sarcopenia, as diseases with high incidence of the elderly, have been confirmed as new complications of diabetes mellitus. This article reviews the relationship between diabetes mellitus, sarcopenia and osteoporosis as well as the potential biological mechanism, aiming to improve people’s understanding of diabetes mellitus, sarcopenia and osteoporosis, and to provide new ideas for their diagnosis, prevention and comprehensive treatment.
文章引用：李金霞, 杨历新. 2型糖尿病患者合并肌少症与骨质疏松关系的研究进展[J]. 临床医学进展, 2021, 11(7): 3191-3195. https://doi.org/10.12677/ACM.2021.117463

参考文献

[1] Perkisas, S. and Vandewoude, M. (2016) Where Frailty Meets Diabetes. Diabetes/Metabolism Research and Reviews, 32, 261-267. [Google Scholar] [CrossRef] [PubMed]
[2] Kim, T.N., Lee, E.J., Hong, J.W., et al. (2016) Relationship between Sarcopenia and Albuminuria: The 2011 Korea National Health and Nutrition Examination Survey. Medicine, 95, e2500. [Google Scholar] [CrossRef] 
[3] Souza, A.B.F., Nascimento, D.A.C., Rodrigues, I.J.M., et al. (2019) Association between Sarcopenia and Diabetes in Community Dwelling Elderly in the Amazon Region—Viver Mais Project. Archives of Gerontology and Geriatrics, 83, 121-125. [Google Scholar] [CrossRef] [PubMed]
[4] Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., et al. (2010) Sarcopenia: European Consensus on Definition and Diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and Ageing, 39, 412-423. [Google Scholar] [CrossRef] [PubMed]
[5] Kim, T.N. and Choi, K.M. (2013) Sarcopenia: Definition, Epidemiology, and Pathophysiology. Journal of Bone Metabolism, 20, 1-10. [Google Scholar] [CrossRef] [PubMed]
[6] Morley, J.E., Malmstrom, T.K., Rodriguez-Mañas, L., et al. (2014) Frailty, Sarcopenia and Diabetes. Journal of the American Medical Directors Association, 15, 853-859. [Google Scholar] [CrossRef] [PubMed]
[7] Chan, R., Leung, J. and Woo, J. (2016) A Prospective Cohort Study to Examine the Association between Dietary Patterns and Sarcopenia in Chinese Community-Dwelling Older People in Hong Kong. Journal of the American Medical Directors Association, 17, 336-342. [Google Scholar] [CrossRef] [PubMed]
[8] Kim, T.N., Park, M.S., Yang, S.J., et al. (2010) Prevalence and Determinant Factors of Sarcopenia in Patients with Type 2 Diabetes: The Korean Sarcopenic Obesity Study (KSOS). Diabetes Care, 33, 1497-1499. [Google Scholar] [CrossRef] [PubMed]
[9] Argilés, J.M., Campos, N., Lopez-Pedrosa, J.M., et al. (2016) Skeletal Muscle Regulates Metabolism via Interorgan Crosstalk: Roles in Health and Disease. Journal of the American Medical Directors Association, 17, 789-796. [Google Scholar] [CrossRef] [PubMed]
[10] Kim, K.S., Park, K.S., Kim, M.J., et al. (2014) Type 2 Diabetes Is Associated with Low Muscle Mass in Older Adults. Geriatrics & Gerontology International, 14, 115-121. [Google Scholar] [CrossRef] [PubMed]
[11] Pechmann, L.M., Jonasson, T.H., Canossa, V.S., et al. (2020) Sarcopenia in Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study. International Journal of Endocrinology, 2020, Article ID: 7841390. [Google Scholar] [CrossRef] [PubMed]
[12] Koh, W.P., Wang, R., Ang, L.W., et al. (2010) Diabetes and Risk of Hip Fracture in the Singapore Chinese Health Study. Diabetes Care, 33, 1766-1770. [Google Scholar] [CrossRef] [PubMed]
[13] Hygum, K., Starup-Linde, J. and Langdahl, B.L. (2019) Diabetes and Bone. Osteoporosis and Sarcopenia, 5, 29-37. [Google Scholar] [CrossRef] [PubMed]
[14] Andersohn, F., Suissa, S. and Garbe, E. (2008) Re: Biphasic Fracture Risk in Diabetes: A Population-Based Study. Bone, 42, 235, 236. [Google Scholar] [CrossRef] [PubMed]
[15] Cortet, B., Lucas, S., Legroux-Gerot, I., et al. (2019) Bone Disorders Associated with Diabetes Mellitus and Its Treatments. Joint Bone Spine, 86, 315-320. [Google Scholar] [CrossRef] [PubMed]
[16] Martineau, P. and Leslie, W.D. (2017) Trabecular Bone Score (TBS): Method and Applications. Bone, 104, 66-72. [Google Scholar] [CrossRef] [PubMed]
[17] Watts, N.B., Bilezikian, J.P., Usiskin, K., et al. (2016) Effects of Canagliflozin on Fracture Risk in Patients with Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology and Metabolism, 101, 157-166. [Google Scholar] [CrossRef] [PubMed]
[18] Napoli, N., Strotmeyer, E.S., Ensrud, K.E., et al. (2014) Fracture Risk in Diabetic Elderly Men: The MrOS Study. Diabetologia, 57, 2057-2065. [Google Scholar] [CrossRef] [PubMed]
[19] Chandran, M. (2017) Diabetes Drug Effects on the Skeleton. Calcified Tissue International, 100, 133-149. [Google Scholar] [CrossRef] [PubMed]
[20] Su, B., Sheng, H., Zhang, M., et al. (2015) Risk of Bone Fractures Associated with Glucagon-Like Peptide-1 Receptor Agonists’ Treatment: A Meta-Analysis of Randomized Controlled Trials. Endocrine, 48, 107-115. [Google Scholar] [CrossRef] [PubMed]
[21] Park, H.S., Lim, J.S. and Lim, S.K. (2019) Determinants of Bone Mass and Insulin Resistance in Korean Postmenopausal Women: Muscle Area, Strength, or Composition? Yonsei Medical Journal, 60, 742-750. [Google Scholar] [CrossRef] [PubMed]
[22] He, Q., Wang, X., Yang, C., et al. (2020) Metabolic and Nutritional Characteristics in Middle-Aged and Elderly Sarcopenia Patients with Type 2 Diabetes. Journal of Diabetes Research, 2020, Article ID: 6973469. [Google Scholar] [CrossRef] [PubMed]
[23] Maratova, K., Soucek, O., Matyskova, J., et al. (2018) Muscle Functions and Bone Strength Are Impaired in Adolescents with Type 1 Diabetes. Bone, 106, 22-27. [Google Scholar] [CrossRef] 
[24] He, H., Liu, Y., Tian, Q., et al. (2015) Relationship of Sarcopenia and Body Composition with Osteoporosis. Osteoporosis International, 27, 473-482. [Google Scholar] [CrossRef] [PubMed]
[25] Pereira, F.B., Leite, A.F. and de Paula, A.P. (2015) Relationship between Pre-Sarcopenia, Sarcopenia and Bone Mineral Density in Elderly Men. Archives of Endocrinology and Metabolism, 59, 59-65. [Google Scholar] [CrossRef] [PubMed]
[26] Elkina, Y., von Haehling, S., Anker, S.D., et al. (2011) The Role of Myostatin in Muscle Wasting: An Overview. Journal of Cachexia, Sarcopenia and Muscle, 2, 143-151. [Google Scholar] [CrossRef] [PubMed]
[27] Dankbar, B., Fennen, M., Brunert, D., et al. (2015) Myostatin Is a Direct Regulator of Osteoclast Differentiation and Its Inhibition Reduces Inflammatory Joint Destruction in Mice. Nature Medicine, 21, 1085-1090. [Google Scholar] [CrossRef] [PubMed]
[28] Verschueren, S., Gielen, E., O’Neill, T.W., et al. (2013) Sarcopenia and Its Relationship with Bone Mineral Density in Middle-Aged and Elderly European Men. Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 24, 87-98. [Google Scholar] [CrossRef] [PubMed]

为你推荐